For instance, Jang et al revealed that ANT1 overexpression induced apoptosis in breast cancer cells and strongly suppressed tumor development both in vitro and in vivo, suggesting that ANT1 might be an effective target for breast cancer treatment. This evidence concerns the gene SLC25A4 and breast carcinoma.